Business Wire12h
FDA Approves Genentech’s Susvimo as the First and Only Continuous Delivery Treatment for the Leading Cause of Diabetes-Related Blindness
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug ...
Why Are Investigators Focused on Night-Vision Goggles in the Deadly Midair Crash?
Investigators have yet to determine whether the crew of an Army helicopter was wearing the devices when the Black Hawk ...